A large proportion of all microchips produced throughout the world are made with optics from Carl Zeiss. Carl Zeiss is the market leader in lithography optics — the basic technology required for microchip production.
Carl Zeiss plays a key role in making microchips increasingly smaller, powerful and affordable.
Measuring solutions from Carl Zeiss are used to make various components — from micro and macro parts, up to large ship engines and wind turbines — more robust, safer and more energy efficient. Industrial measuring technology from
Carl Zeiss ensures maximum standards of quality wherever high precision is a must.
Carl Zeiss develops and distributes innovative microscope systems for biomedical research and materials inspection. They enable researchers to observe even the tiniest structures and processes in living organisms, and thus gain key insights and the new knowledge.
Medical systems from Carl Zeiss are used in ophthalmology, neurosurgery, and ear, nose and throat surgery. Office-based doctors also put their trust in the know-how of Carl Zeiss. Diagnostic and therapy systems help healthcare professionals achieve better treatment outcomes.
Carl Zeiss stands for optimal visual comfort: the company develops and manufactures innovative eyeglass lenses and systems for vision testing.
Carl Zeiss is the world number two in the eyeglass lens market.
Carl Zeiss brings the night sky to planetariums and breathtakingly crisp images to the silver screen. Binoculars and spotting scopes visualize the fascinating details of nature while optoelectronic solutions from Carl Zeiss ensure greater safety and security.
|Industries||Optical and optoelectronic
|Business groups / strategic business units
||Semiconductor Manufacturing Technology
Medical Technology (listed on the TecDAX as
Carl Zeiss Meditec AG)
|Locations||Headquartered in Oberkochen, Germany;
represented in more than 30 countries
around the world.
|Revenue||EUR 4.163 billion (Fiscal year 2011/12)|
|Employees||Approx. 24,000 worldwide,
including around 10,000 in Germany
|Executive Board||Dr. Michael Kaschke (CEO)
Thomas Spitzenpfeil (CFO)
Dr. Hermann Gerlinger
|Fiscal Year||1 October until 30 September|
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company's approx. 24,000 employees generated revenue of about 4.163 billion euros. In the markets for
Carl Zeiss has contributed to technological progress all over the world for more than 160 years and enhances the quality of life of many people around the globe.
The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries.
Carl Zeiss is present in over 40 countries around the globe with about 40 production sites, over 50 sales and service locations and approximately 20 research and development centers. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.
The Carl Zeiss Group is organized into five business groups with a total of 13 strategic business units. The business groups and strategic business units produce and distribute optical systems such as lithography systems, industrial measuring technology, microscopes, surgical microscopes, ophthalmic diagnostic and therapy systems, eyeglass lenses, planetarium technology, cine and camera lenses, binoculars, riflescopes and spotting scopes.
Carl Zeiss AG manages the Group in its role as a strategic holding company.
Its primary function is the ongoing development of the business activities and of the corporate portfolio. It also provides the corporate management and service functions.